Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TeleDaddy was a U.S. direct-to-consumer digital health and telemedicine company that combined online medical consultations, prescription fulfillment, and pharmacy delivery services. Public company-profile and press-release materials describe offerings focused initially on men’s health, especially erectile dysfunction treatment, with planned expansion into hair loss treatment, women’s birth control, broader virtual primary care, and online pharmacy services. The business appears to have operated as a telehealth platform rather than a therapeutics developer, and there is no evidence of a drug-development pipeline in biotech or pharma. Available sources also indicate the company was marketed for sale in 2021-2022 and is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TeleDaddy.